Effect of renal impairment on cognitive function during a 3-year follow up in elderly patients with type 2 diabetes: Association with microinflammation

Journal of Diabetes Investigation

Volumn 5, Issue 5, 2014, Pages 597-605

  Kawamura, Takahiko ^a   Umemura, Toshitaka ^a   Umegaki, Hiroyuki ^a   Imamine, Rui ^a   Kawano, Naoko ^a   Tanaka, Chiai ^a   Kawai, Mariko ^a   Minatoguchi, Makiko ^a   Kusama, Minoru ^a   Kouchi, Yu ^a   Watarai, Atsuko ^b   Kanai, Akio ^a   Nakashima, Eitaro ^a   Hotta, Nigishi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cognitive impairment; Microinflammation; Renal impairment

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TUMOR NECROSIS FACTOR ALPHA;

AGED; ALBUMINURIA; ARTICLE; BLOOD SAMPLING; COGNITION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DIGIT SYMBOL SUBSTITUTION TEST; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY DYSFUNCTION; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROINFLAMMATION; MINI MENTAL STATE EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PSYCHOLOGIC TEST; RECALL; RISK FACTOR; SCORING SYSTEM; STROOP TEST; SYSTOLIC BLOOD PRESSURE; VERY ELDERLY;

EID: 84908571341     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12190     Document Type: Article

References (44)

1. Ott A, Stolk RP, van Harskamp F, et al. Diabetes mellitus and the risk of dementia. The Rotterdam Study. Neurology 1999; 53: 1937-1942.
2. Ohara T, Doi Y, Ninomiya T, et al. Glucose tolerance status and risk of dementia in the community. The Hisayama Study. Neurology 2011; 77: 1126-1134.
3. Kurella Tamura M, Wadley V, Yaffe K, et al. Kidney function and cognitive impairment in US adults: The REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis 2008; 52: 227-234.
4. Murray AM, Barzilay JI, Lovato JF, et al. Biomarkers of renal function and cognitive impairment in patients with diabetes. Diabetes Care 2011; 34: 1827-1832.
5. Kurella Tamura M, Muntner P, Wadley V, et al. Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States. Am J Kidney Dis 2011; 58: 756-763.
6. Kawamura T, Umemura T, Hotta N. Cognitive impairment in diabetic patients: can diabetic control prevent cognitive decline? J Diabetes Invest 2012; 3: 413-423.
7. Thompson CS, Hakim AM. Living beyond our physiological means. Small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis. Stroke 2009; 40: e322-e330.
8. Murray AM. The brain and the kidney connection. A model of accelerated vascular cognitive impairment. Neurology 2009; 73: 916-917.
9. Mogi M, Horiuchi M. Clinical interaction between brain and kidney in small vessel disease. Cardiol Res Pract 2011; 2011: 306189.
10. Wada M, Nagasawa H, Iseki C, et al. Cerebral small vessel disease and chronic kidney disease (CKD): results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 2008; 272: 36-42.
11. Bouchi R, Babazono T, Yoshida N, et al. Relationship between chronic kidney disease and silent cerebral infarction in patients with Type 2 diabetes. Diabet Med 2010; 27: 538-543.
12. Weiner DE, Bartolomei K, Scott T, et al. Albuminuria, cognitive functioning, and white matter hyperintensities in Homebound elders. Am J Kidney Dis 2009; 53: 438-447.
13. de Bresser J, Reijmer YD, van den Berg E, et al. Microvascular deteminants of cognitive decline and brain volume change in elderly patients with type 2 diabetes. Dement Geriatr Cogn Disord 2010; 30: 381-386.
14. Imamine R, Kawamura T, Umemura T, et al. Does cerebral small vessel disease predict future decline of cognitive function in well controlled elderly patients with type 2 diabetes? Diabetes Res Clin Pract 2011; 94: 91-99.
15. Umemura T, Kawamura T, Umegaki H, et al. Association of chronic kidney disease and cerebral small-vessel disease with cognitive impairment in elderly patients with type 2 diabetes. Dement Geriatr Cogn Dis Extra 2013; 3: 212-222.
16. Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 2008; 19: 433-442.
17. Sahakyan K, Klein BEF, Lee KE, et al. Inflammatory and endothelial dysfunction markers and proteinuria with type 1 diabetes mellitus. Eur J Endocrinol 2010; 162: 1101-1105.
18. Shikata K, Makino H. Microinflammation in the pathogenesis of diabetic nephropathy. J Diabetes Invest 2013; 4: 142-149.
19. Upadhyay A, Larson MG, Guo C-Y, et al. Inflammation, kidney function and albuminuria in the Framingham offspring cohort. Nephrol Dial Transplant 2011; 26: 920-926.
20. Shankar A, Sun L, Klein BEK, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int 2011; 80: 1231-1238.
21. Suzuki M, Umegaki H, Ieda S, et al. Factors associated with cognitive impairment in elderly patients with diabetes mellitus. J Am Geriatr Soc 2006; 54: 558-559.
22. Marioni RE, Strachan MW, Reynolds RM, et al. Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes. The Edinburgh Type 2 Diabetes Study. Diabetes 2010; 59: 710-713.
23. Tan ZS, Beiser AS, Vasan RS, et al. Inflammatory markers and the risk of Alzheimer disease. The Framingham Study. Neurology 2007; 68: 1902-1908.
24. Hoshi T, Yamagami H, Furukado S, et al. Serum inflammatory proteins and frontal lobe dysfunction in patients with cardiovascular risk factors. Eur J Neurol 2010; 17: 1134-1140.
25. Wersching H, Duning T, Lohmann H, et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 2010; 74: 1022-1029.
26. Tombaugh TN, McIntyre NJ. The mini-mental state examination. A comprehensive review. J Am Geriatr Soc 1992; 40: 922-935.
27. Mohs RC, Rosen WG, Davis KL. The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull 1983; 19: 448-450.
28. Shinagawa F, Kobayashi S, Fujita K, et al. Japanese Manual for the Wechsler Adult Intelligence Scale-Revised. 1990; Nihon-bunka-kagaku-sya. Tokyo; 1990: 115-8 (Japanese).
29. Stoop JR. Studies of interference in serial verbal reactions. J Exp Psychol 1935; 18: 643-662.
30. Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
31. Kashiwagi A, Kasuga M, Araki E, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Invest 2012; 3: 39-40.
32. Japan Diabetes Society. Treatment Guide for Diabetes. BUNKODO. Co., Ltd., Tokyo, Japan, 2007; 21-23.
33. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 2008; 31: 2103-2107.
34. Jacobson AM, Ryan CM, Cleary PA, et al. Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of diabetes control and complications trial (DCCT) cohort. Diabetologia 2011; 54: 245-255.
35. Barzilay JI, Gao P, O'Donnell M, et al. Albuminuria and decline in cognitive function. The ONTARGET/TRANSCEND Studies. Arch Intern Med 2011; 171: 142-150.
36. Etgen T, Chonchol M, Förstl H, et al. Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 2012; 35: 474-482.
37. Barzilay JI, Fitzpatrick AL, Luchsinger J, et al. Albuminuria and dementia in the elderly: a community study. Am J Kidney Dis 2008; 52: 216-226.
38. Joosten H, Izaks GJ, Slates JPJ, et al. Association of cognitive function with albuminuria and eGFR in the general population. Clin J Am Soc Nephrol 2011; 6: 1400-1409.
39. Barzilay J, Lovato JF, Murray AM, et al. Albuminuria and cognitive decline in people with diabetes and normal renal function. Clin J Am Soc Nephrol 2013; 8: 1907-2013.
40. Jokinen H, Gouw AA, Madureria S, et al. Incident lacunes influence cognitive decline. The LADIS study. Neurology 2011; 76: 1872-1878.
41. Wardlaw JM, Sandercock PAG, Dennis MS, et al. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 2003; 34: 806-812.
42. Hoshi T, Kitagawa K, Yamagami H, et al. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005; 36: 768-772.
43. Kawamura T, Umemura T, Kanai A, et al. Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus. Metabolism 2006; 55: 461-466.
44. Umemura T, Kawamura T, Umegaki H, et al. Endothelial and inflammatory markers in relation to progression of ischaemic cerebral small-vessel disease and cognitive impairment: a 6-year longitudinal study in patients with type 2 diabetes mellitus. J Neurol Neurosurg Psychiatry 2011; 82: 1186-1194.